We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Fast and Easy Test Could Revolutionize Blood Transfusions

By LabMedica International staff writers
Posted on 27 Jan 2026

Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. More...

Although blood units have a fixed expiration date, cells from different donors age at different rates, which can affect how well transfusions work, especially in vulnerable patients. Researchers have now developed a fast, chip-based test that can rapidly evaluate red blood cell quality after storage, offering a potential new tool to better manage blood supplies.

The test, developed through a collaboration between the University of Colorado Boulder (Boulder, CO, USA) and the University of Colorado Anschutz (Aurora, CO), fits on a single microchip and is designed to deliver results in about two minutes. The device, called a surface acoustic wave hemolysis assay, uses vibrations generated on a lithium niobate wafer to mechanically stress red blood cells. As the cells heat up and rupture, the system captures information that reflects membrane strength and overall cell health.

In laboratory tests using donor red blood cells, the researchers observed that some samples hemolyzed at lower temperatures than others. These samples also showed distinct metabolite patterns previously linked to aging red blood cells. The findings, published in Lab on a Chip, suggest that older or more fragile cells break down faster under acoustic stress, making the method a potential indicator of blood quality after storage.

If validated further, the chip-based test could help blood centers allocate higher-quality units to patients who need them most, such as children or individuals with conditions like sickle cell disease who require frequent transfusions. It may also reduce waste by improving decision-making around stored blood. In addition to transfusion medicine, the researchers believe similar lab-on-a-chip systems could be adapted to screen for blood-related diseases or monitor protein and metabolite changes linked to various health conditions.

“Our vision is to have a chip the size of a dime that you can plug into your cell phone,” said Associate Professor Xiaoyun Ding, senior author of the study. “It could use your phone’s camera and an app to read out the results in just two minutes.”

Related Links:
University of Colorado Boulder
University of Colorado Anschutz


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.